The Drugs for Neglected Diseases initiative (DNDi) is an international, not-for-profit research and development (R&D) organization that develops and delivers new treatments for neglected diseases affecting millions of the world’s poorest people.
Together with more than 200 public research and industry allies worldwide, we use the power of partnership, innovation, open science, and advocacy to find solutions to a great injustice: the lack of medicines for life-threatening diseases that disproportionately impact poor and marginalized people. Driven by collaboration, not competition, and by patients’ needs, not profits, we promote equitable access, foster inclusive and sustainable solutions, and advocate for a more effective global biomedical R&D system that meets the needs of neglected patients.
Since our inception, DNDi has delivered 13 new treatments for people with sleeping sickness, visceral leishmaniasis, Chagas disease, HIV, hepatitis C, and malaria that have saved millions of lives. We now aim to deliver an additional 11-14 new treatments by 2028 – addressing R&D gaps for neglected tropical diseases and viral infections, including new pandemic-prone diseases (such as Covid-19) and climate-sensitive diseases (such as dengue) with a focus on the needs of patients in low- and middle-income countries.
With more than 240+ employees of 30+ nationalities located in nine offices on four continents, DNDi is committed to diversity, equity, and inclusion as essential parts of our culture and key drivers of our success. We encourage candidates of diverse profiles and backgrounds to apply.
The R&D organization includes three clusters of Diseases expert teams: NTD/Mycetoma and Leishmaniasis, NTD/Chagas-Filarial-HAT and Viral Diseases. Integrated Clinical Development Sciences (Drug Safety & Pharmacovigilance, Clinical Quality Assurance and Translational Sciences), Regulatory Sciences, Global Clinical Operations, R&D Portfolio and Planning, Discovery and Pharmaceutical Development teams complement the R&D expertise. Projects review, Science and strategy is managed by the Scientific Internal Review Committee (SIRC); The R&D Coordination team lead the R&D organization for all other topics.
The Senior Drug Safety Physician provides support to the Global Drug Safety and Pharmacovigilance (DSPV) function (based in Switzerland) in relation with clinical studies conducted and/or sponsored by DNDi (conducted in Africa, Latin America, Asia, India and other regions) and overall drug safety/pharmacovigilance expertise, and contributes to the development and registration of new treatments for Neglected Diseases.
This role oversees clinical safety activities on studies/programs assigned to the Senior Drug Safety Physician and provide medical expertise to the DSPV team.
Specific job responsibilities
Tasks and responsibilities
The Senior Drug Safety Physician will be responsible for the following clinical safety activities, primarily (but not exclusively) concerning assigned clinical studies/activities:
- Support the Head of Drug Safety and Pharmacovigilance (DSPV) in ensuring that all Pharmacovigilance -related activities related to the management of DNDi-sponsored clinical studies are performed by trained personnel and compliant with applicable local/international safety reporting requirements
- Bring medical expertise to drug safety activities for assigned trials and products.
- Provide support for Drug Safety Scientists (non-medically trained) and other Drug Safety Physicians in the DSPV team
- Assist the function Head in training and mentoring DSPV team colleagues including on interpretation of clinical safety data and analysis preparation and safety risk management activities
- Subject matter expert in clinical safety data interpretation, clinical safety analysis preparation/ Benefit/risk assessment within Periodic safety update reports (together with product/trial medical responsible and DSPV Head), or Subject matter expert in signal detection activities, safety risk management activities and safety profile/safety reference information maintenance
- Subject matter expert in interpretation of regulatory aspects of clinical safety/pharmacovigilance
- Regular collaboration with other DSPV team members and Pharmacovigilance services providers, Clinical Research Organizations (CROs), DNDi regional offices and Disease/clinical program leadership
Act as Drug Safety Product/Project Responsible (DS PR) for assigned product/project (s):
- Coordinate the Product Safety Monitoring Sub-Team (PSMT) related to assigned product(s)/projects.
- Coordinate the signal management activities, development risk management activities related to assigned product(s) in collaboration with clinical team/PSMT members and as necessary, other PV team members.
- Coordinate the preparation of development Risk Management Plan (dRMP) and evaluation of safety data and benefit-risk assessment in collaboration with clinical team/PSMT members and as necessary, other PV team members.
- Propose Pharmacovigilance / Risk management (PV/RM) activities for important identified and potential risks to the PSMT and DNDi Drug Safety Committee (DSC).
- Contribute to the maintenance and update of safety profile information and safety reference documents related to product(s) assigned to the incumbent in collaboration with clinical team/PSMT members and as necessary, other DSPV team members or partners.
- Contribute to marketing authorization registration dossier from a drug safety perspective.
Act as CT Clinical Trial Drug Safety Representative(s) (CT DSR) for assigned clinical trials:
- Coordinate serious adverse events/other Individual Case Safety Reports (ICSRs) medical review and assessment for assigned trials and as per Safety Management plans.
- Ensure the availability and approve study-specific safety management plans and SAE reconciliation plans for the assigned trials, prepared by the PV Service Provider.
- Review of safety cases line listing (LL) and preparation/review of periodic safety reports (i.e. DSUR) and contribution to study-specific periodic progress reports.
- Contribution to study -specific PV training materials and safety-related sections of study documents together with other DSPV team members and in collaboration with clinical team members.
- Support the DS Product/Project Responsible on drug safety activities related to the product: contribution to evaluation of safety data, benefit-risk assessment and dRMP preparation and proposals for PV /risk minimization activities.
Contribution to the preparation/update of PV standard operating procedures, working instructions and templates.
Support the global DSPV function in ensuring that all drug safety-related activities related to the management of DNDi-sponsored clinical studies are performed by trained personnel and compliant with applicable local/international safety reporting requirements.
Regular collaboration with other DSPV team members and PV-services providers, Clinical Research Organizations (CROs), DNDi regional offices and Central clinical program leadership.
Contribution to other DNDi functions from a drug safety perspective.
The above list of responsibilities is not exhaustive, and you may be required to undertake other responsibilities appropriate to your grade.
- Head of Drug Safety and Pharmacovigilance based in Geneva, Switzerland
- Works with clinical teams/program teams, and potentially all units in the R&D department involved in assigned trials/programs.
- Works with the DNDi global PV services provider, DSPV Intervenors and concerned Clinical Research Organizations.
- This role promotes programs and maintains productive relationships by projecting the image of a credible partner and ensures commitment of partners.
Skills and attributes
- Very strong ability to use initiative, prioritize, multi-task, and work well under pressure to meet deadlines.
- Very clear and systematic thinking that demonstrates strong judgment and problem-solving competencies.
- Very strong communication skills in multicultural, multi-lingual environments.
- Over 10 years in Senior role
- Proven ability to work effectively in a team environment and matrix structure.
- Experience of working in public and private sector is highly desirable.
- Proven track record in as drug safety physicians contributing to drug safety, pharmacovigilance.
- Excellent knowledge of Pharmacovigilance (pre- and post-marketing) and Clinical Research/Development
- Excellent knowledge of Regulatory (GCP, GLP and GMP)
- Medical doctor
- Fluency in French and English a must
- Proficiency in other languages an advantage (Spanish, Portuguese...)
- Good knowledge of Microsoft Suite
- One year full-time employment contract, renewable
- Location: UK or Germany (remote) or one of these DNDi office locations (hybrid): Brazil, Democratic Republic of the Congo, India, Japan, Kenya, Malaysia, South Africa
- Please submit your application using the online form.
- Deadline for application: accepting applications until 30 April 2024.
- Only shortlisted candidates will be contacted.
- Application submission for this position may close early if we have enough suitable applicants.